breast cancer metastatic
Showing 26 - 43 of 43
Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)
Active, not recruiting
- Breast Cancer Metastatic
- Ribociclib
- +4 more
-
Ravensburg, GermanyStudienzentrum Onkologie Ravensburg
Mar 7, 2022
Breast Cancer Metastatic, Hormone Receptor Positive Malignant Tumor of Breast Trial in Spain (Combination, Rogaratinib +
Recruiting
- Breast Cancer Metastatic
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Combination, Rogaratinib + palbociclib + fulvestrant
-
Hospitalet de Llobregat, Barcelona, Spain
- +7 more
Feb 8, 2022
Breast Cancer Metastatic Trial in Beijing, Tai Zhou (standard of care, radiotherapy + standard of care)
Recruiting
- Breast Cancer Metastatic
- standard of care
- radiotherapy + standard of care
-
Beijing, Beijing, China
- +1 more
Jan 6, 2022
Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)
Recruiting
- Breast Cancer Stage IV
- +3 more
-
Houston, TexasBaylor College of Medicine
Jun 1, 2021
Chemo-induced Peripheral Neuropathy, Breast Cancer Metastatic, Platinum-resistant Recurrent Ovarian Cancer Trial in Iowa City,
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- +2 more
- Nicotinamide Riboside
-
Iowa City, Iowa
- +1 more
Apr 26, 2021
Breast Cancer Metastatic Trial in Italy (Everolimus, Aromatase Inhibitors)
Completed
- Breast Cancer Metastatic
- Everolimus
- Aromatase Inhibitors
-
Ancona, AN, Italy
- +15 more
Dec 2, 2020
HER2-positive Breast Cancer, Breast Cancer Metastatic Trial in Kansas City, Overland Park, Lee's Summit (Palbociclib 75mg,
Active, not recruiting
- HER2-positive Breast Cancer
- Breast Cancer Metastatic
- Palbociclib 75mg
- +5 more
-
Kansas City, Kansas
- +4 more
Nov 23, 2020
Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Shanghai (SC10914)
Unknown status
- Breast Cancer Metastatic
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 18, 2020
Breast Cancer Metastatic Trial in Seoul
Unknown status
- Breast Cancer Metastatic
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 28, 2020
E-Health Portal for Individualized Treatment Monitoring and
Unknown status
- Breast Cancer Metastatic
- patient-reported-outcomes
-
Tübingen, GermanyDepartment for Women's Health
Feb 10, 2020
Breast Cancer Metastatic Trial in Taipei (Margetuximab, Trastuzumab, Chosen Chemotherapy (Capecitabine))
Unknown status
- Breast Cancer Metastatic
- Margetuximab
- +4 more
-
Taipei, TaiwanNational Taiwan University Hospital
Feb 6, 2020
Cancer Cell Extravasation Through mRNA Analysis of
Completed
- Breast Cancer Metastatic
- Tissue samples collection and cells isolation
-
Milan, ItalyIRCCS Galeazzi Orthopedic Hospital
Aug 5, 2019
Breast Cancer Metastatic Trial in Worldwide (PF-03084014, Docetaxel)
Terminated
- Breast Cancer Metastatic
-
Birmingham, Alabama
- +15 more
Mar 14, 2019
Brain Metastases, Lung Cancer Metastatic, Breast Cancer Metastatic Trial in Jacksonville (DCVax-Direct)
Unknown status
- Brain Metastases
- +2 more
- DCVax-Direct
-
Jacksonville, FloridaMayo Clinic
Aug 17, 2018
Breast Cancer Metastatic Trial in India (Fixed-dose combination of capecitabine and cyclophosphamide SAR439281)
Completed
- Breast Cancer Metastatic
- Fixed-dose combination of capecitabine and cyclophosphamide SAR439281
-
Kollkata, India
- +4 more
Jan 30, 2018
Breast Cancer Metastatic Trial in ShiJiazhuang (Apatinib)
Unknown status
- Breast Cancer Metastatic
-
ShiJiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jan 14, 2018
Breast Cancer Metastatic, Brain Metastases Trial in Beijing (whole brain radiotherapy)
Unknown status
- Breast Cancer Metastatic
- Brain Metastases
- whole brain radiotherapy
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences
Dec 21, 2016
Breast Cancer Metastatic Trial in 809 Madu1-dong, Ilsandong-gu, Goyang-si (Irinotecan plus capecitabine)
Completed
- Breast Cancer Metastatic
- Irinotecan plus capecitabine
-
809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Dec 27, 2011